RENEO PHARMACEUTICALS INC (RPHM) Stock Analyst Ratings
NASDAQ:RPHM - Nasdaq - US75974E1038 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 46% to RPHM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.3. This target is 26.1% above the current price.
RPHM was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about RPHM.
In the previous month the buy percentage consensus was at a similar level.
RPHM was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-12-15 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2023-12-15 | Jefferies | Downgrade | Buy -> Hold |
| 2023-12-15 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-11-15 | William Blair | Initiate | Outperform |
| 2023-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-28 | HC Wainwright & Co. | Initiate | Buy |
| 2023-07-03 | B of A Securities | Initiate | Buy |
| 2022-05-18 | Piper Sandler | Maintains | Overweight |
| 2022-01-27 | Baird | Initiate | Outperform |
| 2021-12-21 | HC Wainwright & Co. | Initiate | Buy |
| 2021-11-22 | Ladenburg Thalmann | Initiate | Buy |
| 2021-05-04 | SVB Leerink | Initiate | Outperform |
| 2021-05-04 | Piper Sandler | Initiate | Overweight |
| 2021-05-04 | Jefferies | Initiate | Buy |